| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/14/2003 | WO2003066869A1 Lmt tumor suppressor gene |
| 08/14/2003 | WO2003066868A1 Retroviral vectors pseudotyped with influenza virus hemagglutinin for gene delivery |
| 08/14/2003 | WO2003066866A2 Cultivation method of transgenic plants for lycopene cyclase |
| 08/14/2003 | WO2003066865A2 Nucleic acid molecule for regulation of gene expression in plants |
| 08/14/2003 | WO2003066864A2 Method for predicting the expression efficiency in cell-free expression systems |
| 08/14/2003 | WO2003066863A1 α-SUBSTITUTED-α,β-UNSATURATED CARBONYL COMPOUND REDUCTASE GENE |
| 08/14/2003 | WO2003066862A1 Cloning of a human prolylhydroxylase-like protein |
| 08/14/2003 | WO2003066861A1 Intein-mediated protein splicing |
| 08/14/2003 | WO2003066860A1 Angiogenesis inhibitors |
| 08/14/2003 | WO2003066858A1 Trans-splicing ribozymes transferring elements derived from sequences encoding fluorescent proteins |
| 08/14/2003 | WO2003066857A2 Elements for modulating plant dna replication, transformation rate, cell cycle regulation and growth |
| 08/14/2003 | WO2003066855A1 Swine rag-1 gene and utilization thereof |
| 08/14/2003 | WO2003066853A1 Identifying dna molecules or proteins involved in producing natural products |
| 08/14/2003 | WO2003066852A2 Plant growth modulation by drl1 and other proteins of the elongator complex |
| 08/14/2003 | WO2003066847A2 Phytase variants |
| 08/14/2003 | WO2003066846A1 Methods for modifying plant responses to stress and correspondingly derived plants |
| 08/14/2003 | WO2003066845A2 Bacteriophage lysin |
| 08/14/2003 | WO2003066842A2 Method for producing recombinant proteins in micro-organisms |
| 08/14/2003 | WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 08/14/2003 | WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 08/14/2003 | WO2003066838A1 A process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
| 08/14/2003 | WO2003066836A2 Udp-glucosyltransferases |
| 08/14/2003 | WO2003066828A2 Zinc finger libraries |
| 08/14/2003 | WO2003066824A2 Albumin-fused kunitz domain peptides |
| 08/14/2003 | WO2003066823A2 Prevention of transgene escape in genetically modified perennials |
| 08/14/2003 | WO2003066822A2 Truncated aggrecanase molecules |
| 08/14/2003 | WO2003066818A2 Secretion, transcription and sporulation genes in bacillus clausii |
| 08/14/2003 | WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE |
| 08/14/2003 | WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system |
| 08/14/2003 | WO2003066809A2 Mismatch endonucleases and methods of use |
| 08/14/2003 | WO2003066805A2 Antisense modulation of complement component c3 expression |
| 08/14/2003 | WO2003066804A2 Thermus scotoductus nucleic acid polymerases |
| 08/14/2003 | WO2003066802A2 Gene expression analysis using nicking agents |
| 08/14/2003 | WO2003066801A2 Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system. |
| 08/14/2003 | WO2003066676A1 Production process of recombinant placental growth factor |
| 08/14/2003 | WO2003066675A1 Gene conferring resistance to phytophthora infestans (late-blight) in solanacea |
| 08/14/2003 | WO2003066667A2 Method and apparatus for performing submicroliter reactions with nucleic acids or proteins |
| 08/14/2003 | WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency |
| 08/14/2003 | WO2003066661A2 Human dr4 antibodies and uses thereof |
| 08/14/2003 | WO2003066650A2 Short interfering rna molecules directed towards a tissue factor coding nucleic acid |
| 08/14/2003 | WO2003066649A1 Immunostimulatory, covalently lipidated oligonucleotides |
| 08/14/2003 | WO2003066108A1 Inactivation of microbes in biological fluids |
| 08/14/2003 | WO2003066093A1 A continuous cell line for the production of vaccines |
| 08/14/2003 | WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 08/14/2003 | WO2003066090A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof |
| 08/14/2003 | WO2003066087A2 Kinases involved in the regulation of energy homeostasis |
| 08/14/2003 | WO2003066085A1 Albumin-fused anti-angiogenesis peptides |
| 08/14/2003 | WO2003066082A1 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage |
| 08/14/2003 | WO2003066078A1 Hiv inhibiting proteins |
| 08/14/2003 | WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 08/14/2003 | WO2003066076A1 Method of protecting living body from foreign factor and composition therefor |
| 08/14/2003 | WO2003066068A1 Hpma-polyamine conjugates and uses therefore |
| 08/14/2003 | WO2003066048A2 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss |
| 08/14/2003 | WO2003066003A2 Anti-pathogen treatements |
| 08/14/2003 | WO2003065984A2 Methods and compositions for treating cardiovascular disease |
| 08/14/2003 | WO2003065977A2 Modified antigen-presenting cells |
| 08/14/2003 | WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use |
| 08/14/2003 | WO2003065871A2 Methods and compositions for treating hematological disorders |
| 08/14/2003 | WO2003065870A2 Digital amplification for detection of mismatch repair deficient tumor cells |
| 08/14/2003 | WO2003065795A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 08/14/2003 | WO2003065793A2 Generation of multiple embryo maize |
| 08/14/2003 | WO2003050240A3 Expression system |
| 08/14/2003 | WO2003048319A3 Nucleotide sequences encoding proteins conferring abiotic stress tolerance in plants |
| 08/14/2003 | WO2003048309A3 Thermus thermophilus nucleic acid polymerases |
| 08/14/2003 | WO2003047617A3 Vaccine |
| 08/14/2003 | WO2003044216A3 Multiplex oligonucleotide addition and target amplification |
| 08/14/2003 | WO2003041652A3 Method of using 18080, a human serine carboxypeptidase family member |
| 08/14/2003 | WO2003040352A9 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted |
| 08/14/2003 | WO2003040342A3 Method for generation of modular polynucleotides using solid supports |
| 08/14/2003 | WO2003032898A3 Modified human thymic stromal lymphopoietin |
| 08/14/2003 | WO2003031934A3 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna |
| 08/14/2003 | WO2003031929A3 Devices and methods for detecting genetic sequences |
| 08/14/2003 | WO2003031568A8 Intracellular signaling molecules |
| 08/14/2003 | WO2003029924A3 Adaptive baseline algorithm for quantitative pcr |
| 08/14/2003 | WO2003029433A3 Chimeric viral vectors for gene therapy |
| 08/14/2003 | WO2003028637A3 Antisense modulation of sphingosine-1-phosphate lyase expression |
| 08/14/2003 | WO2003026395A3 Mo54 gene disruptions, compositions and methods related thereto |
| 08/14/2003 | WO2003025118A3 Multi-site mutagenesis |
| 08/14/2003 | WO2003023365A3 Electrochemical sensor using intercalative, redox-active moieties |
| 08/14/2003 | WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer |
| 08/14/2003 | WO2003018768A3 Transmembrane protein differentially expressed in cancer |
| 08/14/2003 | WO2003018764A3 Novel human proteases and polynucleotides encoding the same |
| 08/14/2003 | WO2003017935A3 Human antibodies specific for interleukin 15 (il-15) |
| 08/14/2003 | WO2003014373A3 Metal-binding proteins |
| 08/14/2003 | WO2003012051A8 Inhibitor of dna methylation |
| 08/14/2003 | WO2003009813A3 Methods of treating neuropilin-mediated diseases |
| 08/14/2003 | WO2003008631A3 Tagging of microorganisms |
| 08/14/2003 | WO2003005810A3 Cloned non-human mammals from contact inhibited donor cells |
| 08/14/2003 | WO2003002713A3 Antibodies to opgl |
| 08/14/2003 | WO2003002069A3 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 08/14/2003 | WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE |
| 08/14/2003 | WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof |
| 08/14/2003 | WO2002097102A3 Modification of plant genomes by inducible site-specific recombination of trans genes |
| 08/14/2003 | WO2002092849A3 Methods |
| 08/14/2003 | WO2002088341A3 P450 proteins |
| 08/14/2003 | WO2002086098A3 A lac operator-repressor system |
| 08/14/2003 | WO2002083902A3 Adenovirus serotype 30 (ad30) fiber protein and uses thereof |
| 08/14/2003 | WO2002079416A3 Transgenic animals resistant to transmissible spongiform encephalopathies |
| 08/14/2003 | WO2002079241A3 Secreted streptococcus pneumoniae proteins |
| 08/14/2003 | WO2002072803A3 Subgenomic replicons of the flavivirus dengue |